Arteriosclerosis and Thrombosis, Vol 11, 80-90, Copyright © 1991 by American Heart Association

ARTICLES

High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects

T Ronnemaa, M Laakso, K Pyorala, V Kallio and P Puukka
Rehabilitation Research Centre of the Social Insurance Institution, Turku, Finland.

The association between fasting plasma insulin level and coronary heart disease (CHD) was studied in 909 non-insulin-dependent diabetic (NIDDM) patients, aged 45-64 years, and in 1,373 nondiabetic control subjects. Both diabetic and nondiabetic subjects with various manifestations of CHD had higher plasma insulin levels than did subjects free of CHD. By plasma insulin quintiles formed according to values in nondiabetic subjects, the age-adjusted prevalence of CHD defined by symptoms and/or electrocardiographic changes in diabetic men was 48.2% in quintiles I + II (lowest), 54.8% in quintiles III + IV, and 65.7% in quintile V (highest) (p = 0.006). The respective prevalences in diabetic women were 53.5%, 59.1%, and 73.3% (p = 0.004); in nondiabetic men, 28.1%, 33.7%, and 43.3%, respectively (p = 0.016); and in nondiabetic women, 28.1%, 34.9%, and 44.3%, respectively (p = 0.007). An essentially similar association was observed between plasma insulin level and definite or possible myocardial infarction (MI). In diabetic subjects, a positive association between plasma insulin level and CHD manifestations was also found when insulin strata were formed using quintile cutoff points determined separately from diabetic subjects. The association between plasma insulin level and the prevalence of CHD or MI disappeared or was weaker, especially in men, when adjustment was made for body mass index, hypertension, and triglyceride or high density lipoprotein (HDL) cholesterol level. The association between high plasma insulin level and CHD was significant in diabetic subjects with a body mass index greater than 27 kg/m2 but not in those diabetics with a body mass index less than or equal to 27 kg/m2. A significant clustering of hypertension, high triglyceride values, and low HDL cholesterol levels was observed in diabetic subjects in the highest insulin quintiles. The results suggest that hyperinsulinemia is an indicator of CHD in both NIDDM patients and nondiabetic subjects. Hyperinsulinemia may be directly atherogenic, but it is more probable that hyperinsulinemia reflects insulin resistance, which may be a factor enhancing atherogenesis by causing adverse changes in many CHD risk factors.

This article has been cited by other articles:

				M. Mohlig, J. Spranger, M. Ristow, A. F H Pfeiffer, T. Schill, H. W Schlosser, L. Moltz, G. Brabant, and C. Schofl Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome Eur. J. Endocrinol., February 1, 2006; 154(2): 295 - 301. [Abstract] [Full Text] [PDF]

				M. H. Tan, D. Johns, and N. B. Glazer Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Clin. Chem., July 1, 2004; 50(7): 1184 - 1188. [Abstract] [Full Text] [PDF]

				W. N. Kernan, S. E. Inzucchi, C. M. Viscoli, L. M. Brass, D. M. Bravata, and R. I. Horwitz Insulin resistance and risk for stroke Neurology, September 24, 2002; 59(6): 809 - 815. [Abstract] [Full Text] [PDF]

				G. A. Nichols, T. A. Hillier, J. R. Erbey, and J. B. Brown Congestive Heart Failure in Type 2 Diabetes: Prevalence, incidence, and risk factors Diabetes Care, September 1, 2001; 24(9): 1614 - 1619. [Abstract] [Full Text] [PDF]

				U. Lindblad, R. D. Langer, D. L. Wingard, R. G. Thomas, and E. L. Barrett-Connor Metabolic Syndrome and Ischemic Heart Disease in Elderly Men and Women Am. J. Epidemiol., March 1, 2001; 153(5): 481 - 489. [Abstract] [Full Text] [PDF]

				A. C. Perry, E. B. Applegate, M. L. Jackson, S. Deprima, R. B. Goldberg, R. Ross, L. Kempner, and B. B. Feldman Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables J Appl Physiol, August 1, 2000; 89(2): 636 - 643. [Abstract] [Full Text] [PDF]

				S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1014 - 1019. [Abstract] [Full Text] [PDF]

				L. S. Sidossis, B. Mittendorfer, E. Walser, D. Chinkes, and R. R. Wolfe Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E798 - E805. [Abstract] [Full Text] [PDF]

				M. L. Goalstone, R. Natarajan, P. R. Standley, M. F. Walsh, J. W. Leitner, K. Carel, S. Scott, J. Nadler, J. R. Sowers, and B. Draznin Insulin Potentiates Platelet-Derived Growth Factor Action in Vascular Smooth Muscle Cells Endocrinology, October 1, 1998; 139(10): 4067 - 4072. [Abstract] [Full Text] [PDF]

				K. Shinozaki, Y. Hattori, M. Suzuki, Y. Hara, A. Kanazawa, H. Takaki, M. Tsushima, and Y. Harano Insulin Resistance as an Independent Risk Factor for Carotid Artery Wall Intima Media Thickening in Vasospastic Angina Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3302 - 3310. [Abstract] [Full Text]

				D. Lender, C. Arauz-Pacheco, B. Adams-Huet, and P. Raskin Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance Hypertension, January 1, 1997; 29(1): 111 - 114. [Abstract] [Full Text]

				K. Shinozaki, H. Naritomi, T. Shimizu, M. Suzuki, M. Ikebuchi, T. Sawada, and Y. Harano Role of Insulin Resistance Associated With Compensatory Hyperinsulinemia in Ischemic Stroke Stroke, January 1, 1996; 27(1): 37 - 43. [Abstract] [Full Text]

				K. Shinozaki, M. Suzuki, M. Ikebuchi, H. Takaki, Y. Hara, M. Tsushima, and Y. Harano Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina Circulation, October 1, 1995; 92(7): 1749 - 1757. [Abstract] [Full Text]